1. Market Research
  2. > Healthcare
  3. > Medical Device
  4. > In Vitro Diagnostics Market Trends
  5. > Point of Care Diagnostics (POC) Market Analysis By Product And Segment Forecasts To 2020

The global market for point of care diagnostics is expected to reach USD 18.7 billion by 2020. Relatively lower turnaround times exhibited by point of care diagnostic tests and the introduction of technologically advanced products enabled with features such as automation and miniaturization, are two of the most significant growth drivers of this market. Moreover, cost effectiveness associated with these tests in terms of infrastructure and staff management coupled with growing global prevalence of diabetes and cardiovascular diseases and rising market penetration rates of point of care diagnostic products in emergency departments and ICUs are expected to drive market demand over the next six years

Growing number of decentralized diagnostic facilities is a significant trend observed in this market. Rise in prevalence of diseases with high unmet medical needs in terms of early diagnosis and treatment such as stroke, sepsis, hypercoagulation and diabetes and reimbursement policies supporting decentralized tests are some of the factors responsible for this market trend.

The hospital glucose testing market dominated the overall market in 2012, accounting for over 10% of the global revenue. Rising global prevalence of diabetes, high market penetration of handheld glucose monitoring devices and growing patient awareness levels in this segment are some of the factors attributing to its market share. Furthermore, OTC and rapid diagnostic tests and cardiac markers market are identified as two of the fastest growing segments. Rapid diagnosis enabling the timely treatment of diseases especially in the cardiovascular disease segment is one of the highest impact rendering drivers of this market.

Further Key findings from the study suggest:

The global point of care diagnostics market was valued at USD 13.5 billion in 2012 and is expected to grow at a CAGR of 4.2% from 2013 to 2020

North America dominated the overall market in 2012 at over 35%. The presence of an encouraging reimbursement framework and the introduction of CLIA (Clinical Laboratory Improvement Amendments) waivers (e.g. waiver received by the HemoCue Albumin 201 System) for point of care test products by the U.S. FDA are some of the drivers of the North America market.

The Asia Pacific point of care diagnostics market on the other hand will grow at the fastest rate during the forecast period owing to the presence of high unmet medical needs coupled with rising healthcare expenditures in emerging countries such as India and China

The global point of care diagnostics market is dominated by key players such as Roche Diagnostics, Abbott Laboratories, Beckman Coulter Inc., Siemens Healthcare, Danaher Corporation, Becton Dickinson and Company

For the purpose of this study, Grand View Research has segmented the global point of care diagnostics market on the basis of product, end-user and region:


Point of Care Diagnostics Product Outlook

Blood Gas/Electrolytes (Centralized and Decentralized)
Infectious Diseases
Hospital Glucose Testing
Cardiac Markers
Hematology
Coagulation
Primary Care Systems (Lipid Profiling and HbA1c Tests)
Decentralized Clinical Chemistry
Urinalysis
Drug Abuse Testing
Fertility
OTC and Rapid Diagnostic Tests
Point of Care Diagnostics End User Outlook

Hospitals
Assisted Living Healthcare Facilities
Laboratories
Home
Clinics
Others
Point of Care Diagnostics Regional Outlook

North America
Europe
Asia Pacific
RoW

Table Of Contents

Point of Care Diagnostics (POC) Market Analysis By Product And Segment Forecasts To 2020
Table of Contents

Chapter 1. Executive Summary

1.1. Point of Care Diagnostics - Industry Summary and Critical Success Factors (CSFs)

Chapter 2. Point of Care Diagnostics Industry Outlook

2.1. Market Segmentation

2.2. Market Size and Growth Prospects

2.3. Point of Care Diagnostics Market Dynamics

2.4. Key Opportunities Prioritized

2.5. Industry Analysis - Porter's

2.6. Point of Care Diagnostics - Company Market Share Analysis

2.7. Point of Care Diagnostics Market PESTEL Analysis, 2012

Chapter 3. Point of Care Diagnostics Product Outlook

3.1. Blood Gas/Electrolytes (Centralized and Decentralized)

3.2. Infectious Diseases

3.3. Hospital Glucose Testing

3.4. Cardiac Markers

3.5. Hematology

3.6. Coagulation

3.7. Primary Care Systems (Lipid Profiling and HbA1c Tests)

3.8. Decentralized Clinical Chemistry

3.9. Urinalysis

3.10. Drug Abuse Testing

3.11. Fertility

3.12. OTC and Rapid Diagnostic Tests

Chapter 4. Point of Care Diagnostics End User Outlook

4.1. Hospitals

4.2. Assisted Living Healthcare Facilities

4.3. Laboratories

4.4. Home

4.5. Clinics

4.6. Others

Chapter 5. Point of Care Diagnostics Regional Outlook

5.1. North America

5.2. Europe

5.3. Asia Pacific

5.4. RoW

Chapter 6. Point of Care Diagnostics Competitive landscape

6.1. Roche Diagnostics

6.1.1 Company Overview

6.1.2 Financial Performance

6.1.3 Product Benchmarking

6.1.4 Strategic Initiatives

6.2 Abbott Laboratories

6.2.1 Company Overview

6.2.2 Financial Performance

6.2.3 Product Benchmarking

6.2.4 Strategic Initiatives

6.3 Siemens Healthcare

6.3.1 Company Overview

6.3.2 Financial Performance

6.3.3 Product Benchmarking

6.3.4 Strategic Initiatives

6.4 Beckman Coulter Inc.

6.4.1 Company Overview

6.4.2 Financial Performance

6.4.3 Product Benchmarking

6.4.4 Strategic Initiatives

6.5 Becton Dickinson and Company

6.5.1 Company Overview

6.5.2 Financial Performance

6.5.3 Product Benchmarking

6.5.4 Strategic Initiatives

6.6 bioMerieux

6.6.1 Company Overview

6.6.2 Financial Performance

6.6.3 Product Benchmarking

6.6.4 Strategic Initiatives

6.7 Johnson and Johnson

6.7.1 Company Overview

6.7.2 Financial Performance

6.7.3 Product Benchmarking

6.7.4 Strategic Initiatives

6.8 Abaxis Inc.

6.8.1 Company Overview

6.8.2 Financial Performance

6.8.3 Product Benchmarking

6.8.4 Strategic Initiatives

6.9 Alere Inc.

6.9.1 Company Overview

6.9.2 Financial Performance

6.9.3 Product Benchmarking

6.9.4 Strategic Initiatives

6.10 Danaher Corporation

6.10.1 Company Overview

6.10.2 Financial Performance

6.10.3 Product Benchmarking

6.10.4 Strategic Initiatives

6.11 Qiagen (AmniSure)

6.11.1 Company Overview

6.11.2 Financial Performance

6.11.3 Product Benchmarking

6.11.4 Strategic Initiatives

6.12 Spectral Diagnostics

6.12.1 Company Overview

6.12.2 Financial Performance

6.12.3 Product Benchmarking

6.12.4 Strategic Initiatives

6.13 Church and Dwight Co. Inc.

6.13.1 Company Overview

6.13.2 Financial Performance

6.13.3 Product Benchmarking

6.13.4 Strategic Initiatives

6.14 Trinity Biotech PLC

6.14.1 Company Overview

6.14.2 Financial Performance

6.14.3 Product Benchmarking

6.14.4 Strategic Initiatives

6.15 Nipro Diagnostics Inc.

6.15.1 Company Overview

6.15.2 Financial Performance

6.15.3 Product Benchmarking

6.15.4 Strategic Initiatives

6.16 Hemocue AB

6.16.1 Company Overview

6.16.2 Financial Performance

6.16.3 Product Benchmarking

6.16.4 Strategic Initiatives

6.17 Nova Biomedical

6.17.1 Company Overview

6.17.2 Financial Performance

6.17.3 Product Benchmarking

6.17.4 Strategic Initiatives

6.18 Pharmatech Inc.

6.18.1 Company Overview

6.18.2 Financial Performance

6.18.3 Product Benchmarking

6.18.4 Strategic Initiatives

6.19 International Technidyne Corporation (ITC)

6.19.1 Company Overview

6.19.2 Financial Performance

6.19.3 Product Benchmarking

6.19.4 Strategic Initiatives

6.20 Quidel Corporation

6.20.1 Company Overview

6.20.2 Financial Performance

6.20.3 Product Benchmarking

6.20.4 Strategic Initiatives

6.21 Sekisui Diagnostics

6.21.1 Company Overview

6.21.2 Financial Performance

6.21.3 Product Benchmarking

6.21.4 Strategic Initiatives

6.22 OraSure Technologies Inc.

6.22.1 Company Overview

6.22.2 Financial Performance

6.22.3 Product Benchmarking

6.22.4 Strategic Initiatives

Chapter 7. Methodology and Scope

7.1. Research Methodology

7.2. Research Scope and Assumption

7.3. List of Data Sources


List of Tables

Point of Care Diagnostics - Industry Summary and Critical Success Factors (CSFs)
Global Point of Care Diagnostics Revenue, 2012 - 2020
Global Point of Care Diagnostics Market Revenue by Region, 2012 - 2020 (USD million)
Global Point of Care Diagnostics Market Revenue by Segments, 2012 - 2020 (USD million)
Global Point of Care Diagnostics Market Revenue by End-Users 2012 - 2020 (USD million)
Global point of care diagnostics demand, by hospitals, 2012 to 2020 (USD million)
Global point of care diagnostics hospital demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by laboratory, 2012 to 2020 (USD million)
Global point of care diagnostics laboratory demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by assisted living healthcare facilities, 2012 to 2020 (USD million)
Global point of care diagnostics assisted living healthcare facilities demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by home, 2012 to 2020 (USD million)
Global point of care diagnostics home demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by clinics, 2012 to 2020 (USD million)
Global point of care diagnostics clinics demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by other facilities, 2012 to 2020 (USD million)
Global point of care diagnostics other facilities demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by blood gas/electrolytes, 2012 to 2020 (USD million)
Global point of care diagnostics for blood gas/electrolytes demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by infectious diseases, 2012 to 2020 (USD million)
Global point of care diagnostics for infectious disease demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by glucose testing, 2012 to 2020 (USD million)
Global point of care diagnostics for glucose testing demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by cardiac markers, 2012 to 2020 (USD million)
Global point of care diagnostics for cardiac markers demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by hematology, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by hematology, 2012 to 2020 (USD million)
Global point of care diagnostics for hematology demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by coagulation, 2012 to 2020 (USD million)
Global point of care diagnostics for coagulation demand, by region, 2012 to 2020 (USD million)
Global wet point of care diagnostic tests for hematology demand, by region, 2012 to 2020 (USD million)
Global wet point of care diagnostic tests for hematology demand, by end-users, 2012 to 2020 (USD million)
Global dry point of care diagnostic tests for hematology demand, by region, 2012 to 2020 (USD million)
Global dry point of care diagnostic tests for hematology demand, by end-users, 2012 to 2020 (USD million)
North America point of care diagnostics demand, by products, 2012 - 2020 (USD million)
North America point of care diagnostics demand, by end-users, 2012 - 2020 (USD million)
Europe point of care diagnostics demand, by products, 2012 - 2020 (USD million)
Europe point of care diagnostics demand, by end-users, 2012 - 2020 (USD million)
Asia Pacific point of care diagnostics demand, by products, 2012 - 2020 (USD million)
Asia Pacific point of care diagnostics demand, by end-users, 2012 - 2020 (USD million)
RoW point of care diagnostics demand, by products, 2012 - 2020 (USD million)
RoW point of care diagnostics demand, by end-users, 2012 - 2020 (USD million)
Global Point of Care Diagnostics Market - Competitive Landscape

List of Figures

Point of Care Diagnostics Market Segmentation
Global Point of Care Diagnostics Market Revenue, 2012 - 2020
Point of Care Diagnostics Market Dynamics
Global population base over the age group of 60 years, 2010 and 2017 (million)
Global diabetes prevalence, 2010 and 2017 (million)
Point Of Care Diagnostics Company Market Share Analysis, 2012
Key Opportunities Prioritized
Industry Analysis - Porter's
Point of Care Diagnostics PESTEL Analysis, 2012
Global point of care diagnostics revenue, by end-users, 2012 and 2020
Global point of care diagnostics demand, by hospitals, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by laboratory, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by assisted living, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by home, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by clinics, 2012 to 2020 (USD million)
Global point of care diagnostics demand, by others, 2012 to 2020 (USD million)
Global point of care diagnostics revenue, by products, 2012 and 2020
Global blood gas/electrolytes demand, by region, 2012 to 2020 (USD million)
Global infectious diseases demand, by region, 2012 to 2020 (USD million)
Global professional hospital glucose testing demand, by region, 2012 to 2020 (USD million)
Global cardiac markers demand, by region, 2012 to 2020 (USD million)
Global hematology demand, by region, 2012 to 2020 (USD million)
Global coagulation demand, by region, 2012 to 2020 (USD million)
Global primary care systems demand, by region, 2012 to 2020 (USD million)
Global decentralized clinical chemistry demand, by region, 2012 to 2020 (USD million)
Global urinalysis demand, by region, 2012 to 2020 (USD million)
Global drug abuse testing demand, by region, 2012 to 2020 (USD million)
Global fertility demand, by region, 2012 to 2020 (USD million)
Global feces demand, by region, 2012 to 2020 (USD million)
Global point of care diagnostics for hematology revenue, by products, 2012 and 2020
Global wet hematology tests demand, by region, 2012 to 2020 (USD million)
Global wet hematology tests demand, by end-users, 2012 to 2020 (USD million)
Global dry hematology tests demand, by region, 2012 to 2020 (USD million)
Global dry hematology tests demand, by end-users, 2012 to 2020 (USD million)
Point of care diagnostics market - company market share analysis, 2012 (%)

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

2016 POC/Point-of-Care Testing Markets: Cancer Clinics, Ambulatory Centers, Surgery Centers, Nursing Homes, Birth Centers-- Volume and Sales Segment Forecasts, Emerging Technologies, Instrumentation Review, Competitive Strategies

  • $ 7500
  • Industry report
  • October 2016
  • by Venture Planning Group

This 1,007-page report provides a comprehensive analysis of the emerging POC market segments, including their dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, ...

Point of Care Diagnostics, BCC Research

Point of Care Diagnostics, BCC Research

  • $ 6650
  • Industry report
  • November 2016
  • by BCC Research

Use this report to: - Review business opportunities in the thriving near-patient testing market. - Learn about the impact of chronic diseases, growing and aging populations. - Receive information about ...

2016 World In Vitro Diagnostic Instrumentation Review

2016 World In Vitro Diagnostic Instrumentation Review

  • $ 6500
  • Industry report
  • October 2016
  • by Venture Planning Group

This new report from VPGMarketResearch.com reviews operating characteristics and features of major automated and semi-automated high-, medium-, and low-volume/POC in vitro diagnostic systems within the ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.